Two cases of acute myocardial infarction during combined chemotherapy in young patients with testicular cancer  by Kawano, Naoko et al.
CT
i
N
T
T
A
a
b
c
a
A
R
R
A
K
A
C
T
Y
I
(
s
u
i
a
i
t
w
(
1
hJournal of Cardiology Cases 7 (2013) e176–e180
Contents lists available at www.sciencedirect.com
Journal  of  Cardiology  Cases
j ourna l h omepa ge: www.elsev ier .com/ locate / j ccase
ase  Report
wo  cases  of  acute  myocardial  infarction  during  combined  chemotherapy
n  young  patients  with  testicular  cancer
aoko  Kawano  (MD)a, Koji  Yamaguchi  (PhD)b,∗, Toshiyuki  Niki  (MD)b, Takashi  Yamamoto  (PhD)c,
akashi  Iwase  (PhD)b,  Yoshio  Taketani  (MD)b,  Takayuki  Ise  (PhD)b, Hirotsugu  Yamada  (PhD)b,
akeshi  Soeki  (PhD,  FJCC)b,  Tetsuzo  Wakatsuki  (PhD)b, Kazuhiro  Kawano  (PhD)c,
kiyoshi  Kakutani  (PhD)c,  Masataka  Sata  (PhD,  FJCC)b
The Post-Graduate Education Center, Tokushima University Hospital, Tokushima, Japan
Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan
Department of Internal Medicine, Tokushima Kouseiren Oe Kyodo Hospital, Yoshinogawa, Japan
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 21 January 2013
eceived in revised form 12 February 2013
ccepted 20 February 2013
eywords:
cute myocardial infarction
ombined chemotherapy
esticular cancer
oung age
a  b  s  t  r  a  c  t
The  two  patients  were  males  aged  over  30 years.  To  treat  testicular  tumors,  combination  chemother-
apy  with  bleomycin,  etoposide,  and  cisplatin  (BEP)  had  been  employed.  In  case  1,  during  the  4th  course
of  BEP  therapy,  thoracic  pain  suddenly  appeared.  Emergency  coronary  angiography  revealed  thrombus
formation.  Under  a  diagnosis  of thrombus-related  acute  myocardial  infarction,  thrombus  aspiration  was
conducted,  and  stent  implantation  was  performed  because  mild  stenosis  and  residual  thrombus  were
observed.  In  case  2,  during  the 2nd  course  of  BEP  therapy,  thoracic  pain  suddenly  appeared.  Emergency
coronary  angiography  revealed  thrombus  formation.  Intracoronary  infusion  of pro-urokinase  was  per-
formed, and  additional  balloon  dilatation  was  conducted  because  mild  stenosis  and  residual  thrombus
were  observed.  In both  cases,  the courses  were  favorable,  and  the levels  of  coagulation  markers  on admis-
sion were  high.  When  selecting  combination  chemotherapy  in  patients  with coronary  risk  factors,  such
as  obesity  and  smoking,  despite  a  young  age,  as demonstrated  in these  two patients,  it may  be  important
to  consider  combination  therapy  with  anticoagulants  or  switching  to  anticancer  drugs  that  do  not  show
vascular  toxicity.
<Learning objective:  When  performing  combination  chemotherapy  with  bleomycin,  etoposide,  and
cisplatin  in  young  patients  with  coronary  risk  factors  such  as  obesity  and  smoking,  it may  be important
to  examine  combination  therapy  with  anticoagulants  or switching  to anticancer  drugs  that  do  not  show
vascular  toxicity,  considering  the possibility  of cardiovascular  disease  onset,  including  acute  myocardial
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infarction.>
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Three-drug combination chemotherapy for testicular tumors
BEP therapy: bleomycin, etoposide, and cisplatin) is performed as
tandard treatment in many hospitals. The side effects of individ-
al drugs, bleomycin-related pulmonary ﬁbrosis, etoposide-related
nterstitial pneumonia, and cisplatin-related peripheral neurop-
thy are known. Furthermore, the side effects of anticancer drugs
nclude vascular toxicity. Several studies have reported various
ypes of vascular occlusion. In this study, we report 2 young patients
ith testicular tumors who developed acute myocardial infarction
AMI) during combination chemotherapy with BEP.
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Case 1
The patient was a 38-year-old male. Neither the medical
nor family history was contributory. Coronary risk factors such
as obesity [body mass index (BMI): 27.8] and previous smok-
ing (25 cigarettes/day × 20 years) were present. High-position
orchidectomy was performed. Pathologically, seminoma was sug-
gested. During the 4th course of BEP therapy, thoracic pain
with constriction in the chest/cold sweating suddenly appeared
10 days after administration. However, neither electrocardiogra-
phy nor hematology showed any abnormalities. After 2 h, anginal
pain/dyspnea/cold sweats appeared again. As electrocardiographic
ﬁndings suggested ischemic heart disease, the patient was referred
to our department. Electrocardiography showed ST segment eleva-
tion at I/II/aVL/V1-6 (Fig. 1A). The laboratory data on admission are
shown in Fig. 1B. Echocardiography revealed hypokinesis involv-
ing the cardiac apex to inferior wall of the left ventricle. Under
vier Ltd. All rights reserved.
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Fig. 1. (A) Electrocardiogram on admission showed sinus rhythm and ST segment elevation at I/II/aVL/V1-6. (B) The data of risk factors on admission were within the
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reatine kinase; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL
emoglobin A1c.
 tentative diagnosis of ischemic heart disease, emergency coro-
ary angiography was performed. A thrombus was  detected in
he proximal region of the left anterior descending vessel. There
ere no stenotic lesions in the right coronary or left circumﬂex
rteries. Under a diagnosis of thrombus-related AMI, thrombus
spiration was conducted twice. Stent implantation (Integrity
tent, 3.5 mm × 18 mm;  Medtronic, Minneapolis, MN, USA) was
erformed because mild stenosis and residual thrombus were
bserved, and favorable reperfusion was achieved (Fig. 2A). The
eak creatine kinase value was 755 IU/L. The D-dimer level on
dmission was high (Fig. 2B).
ase 2
The patient was a 34-year-old male. Neither the medical nor
amily history was contributory. Coronary risk factors such as
besity (BMI: 27.7) and previous smoking (20 cigarettes/day × 15
ears) were present. Orchidectomy was performed to treat a tes-
icular tumor, embryonal carcinoma with a minor component of
horiocarcinoma (stage IIB). After surgery, BEP therapy was  started.
uring the 2nd course, anterior thoracic discomfort suddenly
ppeared in the morning 7 days after administration. As the symp-
oms did not reduce, the patient was referred to the Department
f Cardiology. Electrocardiography showed ST segment elevation
t II/III/aVF/V1-6 (Fig. 3A). The laboratory data on admission are
hown in Fig. 3B. Echocardiography revealed the reduction of wall
otion at the apex of the left ventricle. Under a tentative diag-
osis of ischemic heart disease, emergency coronary angiography
as performed. A thrombus in the proximal region of the left ante-
ior descending vessel and complete occlusion in its distal region
ere observed. There were no stenotic lesions in the right coronary
r left circumﬂex arteries. Under a diagnosis of thrombus-relatedminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK,
-density lipoprotein cholesterol; BUN, blood urea nitrogen; Cr, creatinine; HbA1c,
AMI, intracoronary infusion of pro-urokinase (6000 U) was per-
formed, and additional balloon dilatation (4 mm)  was conducted
because mild stenosis and residual thrombus were observed. Favor-
able reperfusion was  achieved (Fig. 4A). The peak creatine kinase
value was 739 IU/L. The thrombin–antithrombin complex (TAT) and
plasmin-2 plasmin inhibitor complex (PIC) levels on admission
were high (Fig. 4B).
Discussion
As AMI  is caused by coronary atherosclerosis in many patients,
its onset in young persons, as demonstrated in the present cases,
is rare. In our series, coronary angiography revealed thrombus-
related coronary occlusion in the left anterior descending vessel.
Electrocardiography showed a sinus rhythm. Echocardiography
did not reveal any abnormalities, such as intra-cardiac thrombus/
tumor formation or mitral valve stenosis, as etiological factors for
embolism. Therefore, the possibility of thromboembolism-related
myocardial infarction was ruled out. We  speculate that in the
present cases, plaque rupture or plaque erosion might be asso-
ciated with formation of thrombus because the thrombi were
observed in the mild stenotic lesions. However, the precise mecha-
nism was  unclear because intravascular ultrasound or microscopic
angioscopy was  not performed.
The incidence of thrombus formation in cancer patients varies
among investigators: 1–11%. Thrombus formation is frequent in
digestive, pancreatic, lung, and blood cancer patients [1,2]. Some
studies suggested the following mechanisms: in the presence of
cancer, tumor cells directly act on thrombin, promoting blood coag-
ulation; the coagulation capacity is enhanced through interactions
between tumor cells and platelets [3–6]; and the coagulation capac-
ity is enhanced through the enhancement of von Willebrand factor
e178 N. Kawano et al. / Journal of Cardiology Cases 7 (2013) e176–e180
Fig. 2. (A1) Urgent left coronary angiography revealed intracoronary thrombus “(white arrow)” at the mid  left anterior descending artery. (A2) Mild stenosis and resid-
ual  thrombus “(white arrow)” were observed after thrombus aspiration. (A3) Final coronary angiography. (B) Acute myocardial infarction (AMI) occurred 94 days after
chemotherapy induction. Serum levels of D-dimer were elevated.
Fig. 3. (A) Electrocardiogram on admission showed sinus rhythm and ST segment elevation at II/III/aVF/V1-6. (B) The data of risk factors on admission were within the
normal  range. WBC, white blood cells; RBC, red blood cells; Plt, platelets; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK,
creatine kinase; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; BUN, blood urea nitrogen; Cr, creatinine; HbA1c,
hemoglobin A1c.
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tig. 4. (A1) Urgent left coronary angiography revealed intracoronary thrombus “(w
(white arrow)” of the distal LAD. (A2) Final coronary angiography. (B) Acute myoc
hrombin–antithrombin complex (TAT) and plasmin-2 plasmin inhibitor complex
nd inﬂammatory cytokines [7,8]. In the present cases, the D-dimer
Case 1) and TAT-PIC (Case 2) levels on admission were also high.
owever, the data of coagulation and ﬁbrinolysis markers were not
easured before the onset of AMI. Therefore, we do not suppose
hat these cases were strongly related to enhancement of the coag-
lation capacity. Concerning the association between testicular
umors and myocardial infarction, several studies indicated that
umor presence, high-position orchidectomy, and chemotherapy
ncreased the incidence of cardiovascular complications/mortality
ate through a decrease in the blood testosterone level in patients
ith testicular tumors [9,10]. In the present cases, the blood testos-
erone level was not measured; the association was unclear.
Three major factors may  be involved in thrombus forma-
ion, known as the 3 Virchow’s signs: blood stagnation, vascular
ndothelial disorder, and enhancement of blood coagulation. Many
tudies have reported vascular occlusion associated with anti-
ancer drugs [11]. Long-term therapy with bleomycin, which
nduces pulmonary ﬁbrosis, increases interleukin-1 production
n alveolar macrophages. As a mechanism, interleukin-1 pro-
uced in the lung may  act on the vascular endothelium of the
hole body, promoting coagulation [12]. Several studies have
roposed the hypothesis that cisplatin, which is commonly used
or various regimens, may  induce hypomagnesiumemia through
nhancement of the coagulation capacity/tubular disturbance
elated to the arachidonic acid cascade activation-mediated acti-
ation of platelets/vascular endothelial cells, leading to coronary
asospasm [13–15]. In addition, a study indicated that etoposide
ore frequently caused cardiovascular complications compared
o cisplatin [10]. In the two patients presented in this arti-
le, the following mechanism was speculated: topical vascular
ndothelial disorder after anticancer drug administration in the
resence of the enhanced coagulation capacity related to the
ancer-bearing state/administration of anticancer drugs may  lead
o occlusive thrombus formation. However, few studies have
eported monotherapy-induced myocardial infarction; for combi-
ation therapy, respective drugs may  synergistically act in not only
esticular cancer patients but also other cancer patients. Accordingrrow)” at the proximal left anterior descending artery (LAD) and abrupt occlusion
l infarction (AMI) occurred 35 days after chemotherapy induction. Serum levels of
were elevated.
to some studies, chemotherapy increases the risk of cardiovascular
events in testicular tumor patients [16,17]. Another study indicated
that the incidence of cardiovascular events related to BEP therapy
was 1.5 times higher [18].
The interval from the start of chemotherapy until the onset of
myocardial infarction varies among studies: 9 days after the com-
pletion of the 1st course to 18 months after the completion of
6 courses of treatment [19]. The timing of onset also differed
between the present cases: 10 days after the start of the 4th course
and 7 days after the start of the 2nd course, respectively. The asso-
ciation between the chemotherapy period and onset of myocardial
infarction remains to be clariﬁed.
Furthermore, the side effects of high-dose steroids include
myocardial infarction. Erstad et al. reported that fatal cardiovascu-
lar complications, including myocardial infarction, were frequent
in patients who received rapid administration at 250 mg  or more
[calculated as methylprednisolone (M-PSL)], those in whom the
timing of onset was  during or immediately after administration,
and those with kidney disease [20]. In Case 1, the dose was con-
verted to an M-PSL dose of 33 mg,  which was  low. In Case 2, the
timing of onset was  3 days after the completion of administration.
Therefore, steroids may  not have been involved in either patient.
When performing combination chemotherapy with BEP in
young patients with coronary risk factors such as obesity and smok-
ing, it may  be important to examine combination therapy with
anticoagulants or switching to anticancer drugs that do not show
vascular toxicity, considering the possibility of cardiovascular dis-
ease onset, including AMI.
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